+

PH30305A - Improved meningococcal polysaccharide conjugate vaccine - Google Patents

Improved meningococcal polysaccharide conjugate vaccine

Info

Publication number
PH30305A
PH30305A PH41724A PH41724A PH30305A PH 30305 A PH30305 A PH 30305A PH 41724 A PH41724 A PH 41724A PH 41724 A PH41724 A PH 41724A PH 30305 A PH30305 A PH 30305A
Authority
PH
Philippines
Prior art keywords
conjugate vaccine
polysaccharide conjugate
meningococcal polysaccharide
improved
improved meningococcal
Prior art date
Application number
PH41724A
Other languages
English (en)
Inventor
Harold J Jennings
Francis Michon
Original Assignee
Ca Nat Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ca Nat Research Council filed Critical Ca Nat Research Council
Publication of PH30305A publication Critical patent/PH30305A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1217—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
PH41724A 1989-12-14 1990-12-14 Improved meningococcal polysaccharide conjugate vaccine PH30305A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44819589A 1989-12-14 1989-12-14

Publications (1)

Publication Number Publication Date
PH30305A true PH30305A (en) 1997-02-20

Family

ID=23779371

Family Applications (1)

Application Number Title Priority Date Filing Date
PH41724A PH30305A (en) 1989-12-14 1990-12-14 Improved meningococcal polysaccharide conjugate vaccine

Country Status (30)

Country Link
US (3) US5576002A (fr)
EP (1) EP0504202B1 (fr)
JP (1) JP2637845B2 (fr)
KR (1) KR0158436B1 (fr)
CN (4) CN1049223C (fr)
AR (1) AR243934A1 (fr)
AT (1) ATE121947T1 (fr)
AU (1) AU641715B2 (fr)
BR (1) BR9007917A (fr)
CA (1) CA2071811C (fr)
CZ (1) CZ283530B6 (fr)
DE (1) DE69019164T2 (fr)
DK (1) DK0504202T3 (fr)
ES (1) ES2071288T3 (fr)
FI (2) FI104539B (fr)
HR (1) HRP920872A2 (fr)
HU (2) HU9201966D0 (fr)
IE (1) IE68414B1 (fr)
IL (1) IL96676A (fr)
IN (1) IN171747B (fr)
NO (2) NO305275B1 (fr)
NZ (1) NZ236471A (fr)
PH (1) PH30305A (fr)
PL (2) PL166659B1 (fr)
RO (1) RO111416B1 (fr)
RU (1) RU2105568C1 (fr)
SI (1) SI20008B (fr)
WO (1) WO1991008772A1 (fr)
YU (1) YU24391A (fr)
ZA (1) ZA9010065B (fr)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
WO1991008772A1 (fr) * 1989-12-14 1991-06-27 National Research Council Of Canada Vaccin conjugue ameliore a base de polysaccharide de meningocoque
NZ248766A (en) * 1992-09-24 1996-11-26 Ca Nat Research Council Capsular polysaccharide-protein conjugate vaccine against group b streptococcus type ii or v
US6153406A (en) * 1993-07-23 2000-11-28 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane protein P2 from Haemophilus influenzae type B
US5439808A (en) * 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US5700787A (en) * 1994-09-02 1997-12-23 Brigham & Women's Hospital, Inc. Capsular polysaccharide immunomodulator
US5679654A (en) * 1994-09-02 1997-10-21 Brigham & Women's Hospital, Inc. Capsular polysaccharide immunomodulator
US5747287A (en) * 1995-04-28 1998-05-05 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
PT1090642E (pt) * 1995-06-07 2008-09-09 Glaxosmithkline Biolog Sa Vacinas compreendendo um conjugado de antigénio polissacarídico - proteína veículo e proteína veículo livre
US5811102A (en) 1995-06-07 1998-09-22 National Research Council Of Canada Modified meningococcal polysaccharide conjugate vaccines
US6284884B1 (en) 1995-06-07 2001-09-04 North American Vaccine, Inc. Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof
ZA97248B (en) * 1996-01-18 1997-07-18 Rohm & Haas Method for identifying and quantifying polymers utilizing immunoassay techniques
WO1998008874A1 (fr) 1996-08-27 1998-03-05 Chiron Corporation Anticorps monoclonaux definissant des epitopes meningococciques b et leurs utilisations dans la preparation de compositions vaccinales
EP0939647B2 (fr) 1996-08-27 2006-07-12 Chiron Corporation Glycoconjugues du groupe serologique b de neisseria meningitidis et procedes pour leur utilisation
US6426074B1 (en) * 1997-03-19 2002-07-30 The Brigham And Women's Hospital Inc. Group B Streptococcus vaccine
US6413520B1 (en) 1997-06-24 2002-07-02 Chiron Corporation Methods of immunizing adults using anti-meningococcal vaccine compositions
CA2301942C (fr) * 1997-08-27 2011-05-31 Chiron Corporation Mimetiques moleculaires des epitopes b meningococciques
EP1051506B2 (fr) 1997-12-23 2019-08-21 Pfizer Ireland Pharmaceuticals Procedures permettant d'extraire et d'isoler des polysaccharides capsulaires bacteriens destines a etre utilises seuls, en tant que vaccins ou, lies a des proteines, en tant que vaccins conjugues
CN1263510C (zh) * 1998-08-19 2006-07-12 巴克斯特健康护理股份有限公司 多糖－蛋白质缀合物或寡糖－蛋白质缀合物、其制备方法及其应用
RU2249463C2 (ru) * 1998-08-19 2005-04-10 Бакстер Хелфкэа С.А. Иммуногенный конъюгат бета-пропионамид-связанного полисахарида с белком, использующийся в качестве вакцины
US6436653B1 (en) 1998-12-15 2002-08-20 Exiqon A/S Method for introduction of reporter groups into bacterial lipopolysaccharide-derived carbohydrates and the subsequent coupling of such derivatives onto solid surfaces
US7083777B1 (en) * 1999-04-02 2006-08-01 The Brigham And Women's Hospital, Inc. Immunomodulating polymers
US6518037B2 (en) * 1999-11-12 2003-02-11 University Of Iowa Research Foundation Two-component system that controls bacterial membrane synthesis
GB9928196D0 (en) * 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
GB0011108D0 (en) * 2000-05-08 2000-06-28 Microscience Ltd Virulence gene and protein and their use
SV2003000753A (es) 2000-12-05 2003-06-16 Brigham & Womens Hospital Uso de polisacaridos zwitterionicos para la especifica modulacion del progreso inmunologico
CN1306956C (zh) * 2001-04-17 2007-03-28 希龙公司 诱导功能活性抗体的脑膜炎球菌b抗原表位的分子模拟物
GB0115176D0 (en) * 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
GB0121591D0 (en) * 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
AR045702A1 (es) 2001-10-03 2005-11-09 Chiron Corp Composiciones de adyuvantes.
NZ535968A (en) * 2002-03-26 2006-08-31 Chiron S Modified saccharides having improved stability in water
MXPA04011248A (es) * 2002-05-14 2005-02-17 Chiron Srl Vacunas mucosales en combinacion para la meningitis bacteriana.
RU2364418C2 (ru) * 2002-08-02 2009-08-20 ГлаксоСмитКлайн Байолоджикалз с.а. ВАКЦИННЫЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ЛИПОПОЛИСАХАРИДЫ ИММУНОТИПА L2 И/ИЛИ L3, ПРОИСХОДЯЩИЕ ИЗ ШТАММА NEISSERIA MENINGITIDIS IgtB-
GB0227346D0 (en) * 2002-11-22 2002-12-31 Chiron Spa 741
EP1638581A2 (fr) 2003-03-31 2006-03-29 The Brigham And Women's Hospital, Inc. Immunomodulateurs zwitterioniques destines au traitement de l'asthme et des allergies
US7731967B2 (en) 2003-04-30 2010-06-08 Novartis Vaccines And Diagnostics, Inc. Compositions for inducing immune responses
US7807824B2 (en) 2003-08-12 2010-10-05 Lipoxen Technologies Limited Sialic acid derivatives for protein derivatisation and conjugation
AU2005258301A1 (en) * 2004-06-23 2006-01-05 Children's Hospital & Research Center At Oakland Polysaccharide derivatives and uses in induction of an immune response
US8148335B2 (en) 2004-06-23 2012-04-03 Children's Hospital & Research Center Oakland De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
GB0428394D0 (en) * 2004-12-24 2005-02-02 Chiron Srl Saccharide conjugate vaccines
ES2377075T5 (es) 2005-06-27 2016-04-29 Glaxosmithkline Biologicals S.A. Composición inmunogénica
WO2007092451A2 (fr) 2006-02-06 2007-08-16 The Brigham And Women's Hospital, Inc. Polysaccharides zwitterioniques pour favoriser la maturation du système immunitaire et la santé
GB0611914D0 (en) 2006-06-15 2006-07-26 Teti Giuseppe Peptides that mimic non-human cross-reactive protective epitopes of the group Bmeningococcal capsulsar polysaccharide
EP1872791A1 (fr) * 2006-06-30 2008-01-02 Institut Pasteur Utilisation de polysaccharides bactériens pour empêcher la formation d'un film biologique
WO2008157590A1 (fr) * 2007-06-20 2008-12-24 Baxter International Inc. Polysaccharides modifiés pour vaccins conjugués
ES2664753T3 (es) 2007-12-07 2018-04-23 Glaxosmithkline Biologicals Sa Composiciones de inducción de respuestas inmunes
WO2010083477A2 (fr) 2009-01-16 2010-07-22 University Of Maryland, Baltimore Vaccin à large spectre contre les salmonelles non typhoïdiques
WO2013009945A1 (fr) 2011-07-12 2013-01-17 The Brigham And Women's Hospital, Inc. Compositions de psa contenant des lipides, procédés d'isolement et procédés pour les utiliser
EP2752403A1 (fr) * 2013-01-08 2014-07-09 Sika Technology AG Amine pour résines époxy à faibles émissions
EP3337321A4 (fr) 2015-08-19 2019-07-17 President and Fellows of Harvard College Compositions de psa lipidés et procédés associés
US11491181B2 (en) 2016-07-15 2022-11-08 President And Fellows Of Harvard College Glycolipid compositions and methods of use
CA3051801A1 (fr) * 2017-01-31 2018-08-09 Pfizer Inc. Compositions de neisseria meningitidis et methodes associees

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4057685A (en) * 1972-02-02 1977-11-08 Abbott Laboratories Chemically modified endotoxin immunizing agent
US4356170A (en) * 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
US4673574A (en) * 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4619828A (en) * 1982-07-06 1986-10-28 Connaught Laboratories, Inc. Polysaccharide exotoxoid conjugate vaccines
US4496538A (en) * 1982-07-06 1985-01-29 Connaught Laboratories, Inc. Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine
US4644059A (en) * 1982-07-06 1987-02-17 Connaught Laboratories, Inc. Haemophilus influenzae B polysaccharide-diptheria toxoid conjugate vaccine
US4695624A (en) * 1984-05-10 1987-09-22 Merck & Co., Inc. Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
US4727136A (en) * 1985-10-01 1988-02-23 Canadian Patents And Development Ltd. Modified meningococcal group B polysaccharide for conjugate vaccine
WO1991008772A1 (fr) * 1989-12-14 1991-06-27 National Research Council Of Canada Vaccin conjugue ameliore a base de polysaccharide de meningocoque

Also Published As

Publication number Publication date
EP0504202B1 (fr) 1995-05-03
CZ283530B6 (cs) 1998-04-15
BR9007917A (pt) 1992-10-20
FI104539B (fi) 2000-02-29
US5902586A (en) 1999-05-11
CA2071811C (fr) 2003-11-04
CN1055541A (zh) 1991-10-23
CN1096516A (zh) 1994-12-21
CZ628490A3 (en) 1997-12-17
US5683699A (en) 1997-11-04
DE69019164T2 (de) 1995-09-07
IN171747B (fr) 1992-12-26
CA2071811A1 (fr) 1991-06-15
CN1049223C (zh) 2000-02-09
HU218146B (hu) 2000-06-28
ES2071288T3 (es) 1995-06-16
CN1100656A (zh) 1995-03-29
DK0504202T3 (da) 1995-10-02
US5576002A (en) 1996-11-19
RO111416B1 (ro) 1996-10-31
CN1036522C (zh) 1997-11-26
NO305275B1 (no) 1999-05-03
JP2637845B2 (ja) 1997-08-06
SI20008A (sl) 2000-02-29
PL166035B1 (pl) 1995-03-31
NO307835B1 (no) 2000-06-05
IL96676A (en) 1996-09-12
EP0504202A1 (fr) 1992-09-23
WO1991008772A1 (fr) 1991-06-27
RU2105568C1 (ru) 1998-02-27
NZ236471A (en) 1992-10-28
AU6898791A (en) 1991-07-18
PL166659B1 (pl) 1995-06-30
NO922316L (no) 1992-08-14
KR0158436B1 (ko) 1998-12-01
ATE121947T1 (de) 1995-05-15
HRP920872A2 (en) 1997-06-30
JPH05505392A (ja) 1993-08-12
DE69019164D1 (de) 1995-06-08
FI19991917L (fi) 1999-09-09
HUT64480A (en) 1994-01-28
CN1036504C (zh) 1997-11-26
CN1100428A (zh) 1995-03-22
ZA9010065B (en) 1992-02-26
FI922737A0 (fi) 1992-06-12
YU24391A (sh) 1995-12-04
IL96676A0 (en) 1991-09-16
CN1072506C (zh) 2001-10-10
PL288271A1 (en) 1991-12-16
NO973311L (no) 1992-08-14
IE904513A1 (en) 1991-06-19
NO922316D0 (no) 1992-06-12
NO973311D0 (no) 1997-07-17
SI20008B (en) 2001-02-28
HU9201966D0 (en) 1992-10-28
IE68414B1 (en) 1996-06-12
AU641715B2 (en) 1993-09-30
AR243934A1 (es) 1993-09-30

Similar Documents

Publication Publication Date Title
PH30305A (en) Improved meningococcal polysaccharide conjugate vaccine
GB8907914D0 (en) Vaccine preparation
HU896283D0 (en) Colon-selective, peroral medical preparation
HUP0103100A3 (en) Immunogenic betha-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide
GB8924438D0 (en) Vaccine composition
HUP9802664A3 (en) Modified meningococcal polysaccharide conjugate vaccines and modified polysaccharides
EP0454735A4 (en) Vaccine composition
GB8921470D0 (en) Vaccines
EP0468714A3 (en) Peptide-polysaccharide-protein conjugate vaccines
PT86286A (en) Conjugate vaccine
AU1118888A (en) Conjugate malaria vaccine
GB9017370D0 (en) Tuberculosis vaccine
GB8918689D0 (en) 25/15 vaccine
GB2232681B (en) Nitro-p-phenylenediamine derivatives
EP0504136A4 (en) Tolerogenic immunoglobulin-protein conjugates
AP9000165A0 (en) Vaccine composition
HU9303207D0 (en) Liposomal polysaccharide vaccines
PL346645A1 (en) IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE
ZA907863B (en) Vaccine conjugate
ZA92536B (en) Pneumococcal polysaccharide conjugate vaccine
AU5560886A (en) Klebsiella capsular polysaccharide vaccine
EP0453452A4 (en) Vaccine
ZA88792B (en) Conjugate malaria vaccine
GB8922651D0 (en) Vaccine
ZA909516B (en) Novel vaccine
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载